Deferred Tax Assets, Valuation Allowance of Serina Therapeutics, Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Serina Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • Serina Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $35,445,000, a 176% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Serina Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $35,445,000 +$22,603,000 +176% 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q4 2023 $12,842,000 -$5,619,000 -30% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q4 2022 $18,461,000 +$244,000 +1.3% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q4 2021 $18,217,000 +$389,000 +2.2% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $17,828,000 +$2,116,000 +13% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q4 2019 $15,712,000 +$3,469,000 +28% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $12,243,000 +$2,197,000 +22% 31 Dec 2018 10-K/A 31 Mar 2020 2019 FY
Q4 2017 $10,046,000 31 Dec 2017 10-K 01 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.